Safe Drugs Act & State Bills Threaten Compounded GLP-1 Access
No se pudo agregar al carrito
Add to Cart failed.
Error al Agregar a Lista de Deseos.
Error al eliminar de la lista de deseos.
Error al añadir a tu biblioteca
Error al seguir el podcast
Error al dejar de seguir el podcast
Safe Drugs Act & State Bills Threaten Compounded GLP-1 Access
-
Narrado por:
-
De:
Here’s a clean, professional Show Notes section you can use:
Show Notes
In this episode, I’m joined by Sabina Hemmi, founder of GLP Winner, to break down the growing wave of federal and state legislation targeting compounded GLP-1 medications.
We discuss:
Why transparent GLP-1 pricing matters
How GLP Winner helps patients compare clinics without deceptive funnels
The federal Safe Drugs Act and emerging state bills
How some legislation could impact all compounding, not just GLP-1s
What this means for hospice care, pediatrics, veterinary medicine, and more
Why patient advocacy at the state level matters right now
The real-life side effects and lived experience behind the policy debate
If you live in a state where legislation is moving, contact your representative and share your story. Patient voices are making a difference.
Connect with Sabina
TikTok: https://www.tiktok.com/@lawliepopInstagram: https://www.instagram.com/lawliepops/YouTube: https://www.youtube.com/@lawliepopX/Twitter: https://x.com/lawliepopSubstack: https://substack.com/@lawliepopLinkedIn: https://www.linkedin.com/in/sabina-hemmi/
Resources
Visit GLP-1 Studio for the latest bill updates and advocacy tools.
Get full access to GLP-1 Studio at glp1studio.substack.com/subscribe